
About Valencia Nutrition
Valencia Nutrition is a publicly listed company based in Mumbai (India) founded in 2013 by Deepthi Anand. Valencia Nutrition is engaged in producing FMCG products focused on nutrition. It operates on a Direct-to-Consumer (D2C) model. Valencia Nutrition has raised $1.78 million across 5 funding rounds from investors including Veer Equity, Orchid Consultancy Services and Manish Turakhia. The company has 33 employees. Valencia Nutrition was last valued at $2.53 million in June 2019. Its chief executive, as recorded, is Deepthi Anand. Its Indian entity Valencia Nutrition Limited reported revenue of βΉ9.58 Cr. Valencia Nutrition offers products and services including Valencia Beverages, Valencia Snacks, and Valencia Perfumes. Its focus areas include Consumer Goods, Fast-Moving Consumer Goods and Nutraceuticals. Its competitors include Auric, Akiva Superfoods and Raskik; 3 of its 3 listed competitors have raised funding.
Company details
Valencia Nutrition Limited is involved in the production and distribution of fast-moving consumer goods with a focus on everyday nutrition. The company operates in sectors such as beverages, snacks, and personal care, offering affordable and accessible products. Solutions are developed by combining cultural ingredients with modern science to address nutritional needs. A presence is established across various industries in India, aiming for innovation and sustainable impact in the FMCG market.
- Headquarters Mumbai, India
- Employees 33
- Founders Deepthi Anand
- Stage Public
- SectorsConsumer
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website valencianutrition.com
- Social LinkedIn Facebook
- Legal Name Valencia Nutrition Ltd.
- Market Cap₹116 Cr
VALENCIA · BSE
- Share Price₹58.00
-0.85% today
- Revenue₹7.88 Cr
FY 2025-26 · -7.0% YoY
- EBITDA₹0.16 Cr
Margin 2.0%
- Net Profit₹1.09 Cr
FY 2025-26 · -4.4% YoY
- P/E (TTM)106.2x
P/B 2.6x
- ROE1.9%
ROCE 1.9%
- Debt / Equity0.21
Interest cover -27.1x
- Total Equity Funding$1.78M (USD)
in 5 rounds
- Latest Funding Round$458.9K (USD), Seed
Jun 2019
- InvestorsVeer Equity
& 7 more
- Employee Count33
Associated legal entities of Valencia Nutrition
Valencia Nutrition operates through Valencia Nutrition Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Valencia Nutrition Limited Listed CIN L51909MH2013PLC381314 | Active | 01 Apr 2013 | Mumbai, Maharashtra | ₹9.6 Cr | 33 | 12 | View details |
Products & Services of Valencia Nutrition
Valencia Nutrition offers a comprehensive portfolio of products and services, including Valencia Beverages, Valencia Snacks, and Valencia Perfumes.
Beverages are offered for everyday nutrition and hydration.
Snacks are provided for quick and accessible consumption.
Perfumes are sold for personal grooming and appeal.
Funding Insights of Valencia Nutrition
Valencia Nutrition has successfully raised a total of $1.78M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $458.9 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.78M
- Total Rounds 5
- Last Round Seed β $458,896
- First Round $350,054
(Mar 2014)
- Investors Count 8
All 5 funding rounds of Valencia Nutrition with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | $458,896 | Seed | $2.53M | Veer Equity | |
| Dec 2017 | $778,399 | Seed | β | Manish Turakhia | |
| Oct 2015 | $131,724 | Angel Round | $1.13M | Rachel Kattukaran | |
| Jul 2015 | $58,263 | Angel Round | $β’β’β’β’β’ | Raj Kumar Elango | |
| Mar 2014 | $350,054 | Seed | $β’β’β’β’β’ | Raj Kumar Elango |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2019 | $2.53M | β’β’β’β’β’β’β’β’ |
| Oct 2015 | $1.13M | β’β’β’β’β’β’β’β’ |
Last known valuation $2.53M (Jun 2019). 8 investors in total: 4 institutional and 4 angel.
Investors in Valencia Nutrition
Valencia Nutrition has secured backing from 8 investors, including institutional and angel investors. Prominent investors backing the company include Veer Equity, Orchid Consultancy Services and Manish Turakhia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provides investment advisory, corporate finance, and global network services. | 1996 | veerequity.com | Mumbai, India | |
Offers IT consultancy, website design, and software development services to businesses. | 2012 | ocs.net.in | Mumbai, India | |
MT Manish Turakhia | unknown_72f4d6d4563042618 | |||
RK Rachel Kattukaran | unknown_02b6dd34d3b7428f9 | |||
VG Venu Gopal Nambiar | unknown_08b97bd4e58d43519 | |||
RK Raj Kumar Elango | unknown_ab658ecc30864ce7a |
Investor details for Valencia Nutrition
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Valencia Nutrition Limited (Valencia Nutrition)
Valencia Nutrition Limited is the primary company behind Valencia Nutrition. The board of Valencia Nutrition Limited currently have 10 directors; the longest-serving is Manish Pravinchandra Turakhia, appointed in 2017. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manish Pravinchandra Turakhia DIN 02265579 | Managing Director | 18 Dec 2017 | 8 yrs 10 mo | Valencia Nutrition Limited |
| Stavan Pravin Ajmera DIN 08112696 | Director | 19 Apr 2018 | 8 yrs 6 mo | Valencia Nutrition Limited |
| Ramanathan Guhesh DIN 03579684 | Director | 19 Apr 2018 | 8 yrs 6 mo | Valencia Nutrition Limited |
| Jaimin Ajay Patwa DIN 08613495 | Director | 11 May 2020 | 6 yrs 5 mo | Valencia Nutrition Limited |
| Jay Jatin Shah DIN 09072405 | Whole-time director | 01 Mar 2021 | 5 yrs 8 mo | Valencia Nutrition Limited |
| Eshanya Guppta DIN 01727743 | Director | 31 May 2021 | 5 yrs 5 mo | Valencia Nutrition Limited |
| Geet Chandrakant Shah DIN 08532430 | Director | 02 Sep 2023 | 3 yrs 2 mo | Valencia Nutrition Limited |
| Meghna Manish Turakhia DIN 07109963 | Director | 02 Sep 2024 | 2 yrs 2 mo | Valencia Nutrition Limited |
| Hiren Rajendra Jain DIN 02789749 | Additional Director | 03 Sep 2026 | 2 mo | Valencia Nutrition Limited |
| Ashish Narendra Kamdar DIN 07691534 | Additional Director | 03 Sep 2026 | 2 mo | Valencia Nutrition Limited |
People of Valencia Nutrition
1 people are tracked at Valencia Nutrition (1 in leadership); the tracked headcount is 33.
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for Valencia Nutrition
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Valencia Nutrition
Valencia Nutrition is a publicly listed company on the BSE with ticker symbol VALENCIA in India, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date06 Jan 2020
- Listed onBSE: 542910
- Listed entityValencia Nutrition Ltd.
- Exchange sectorConsumer non-durables
- ISININE08RT01016
- Share price₹63.90 (-0.16% on the day) · 2026-10-14
- Volume (last session)1,500
Financials of Valencia Nutrition
Exchange-reported figures of Valencia Nutrition Limited, the listed company behind Valencia Nutrition (BSE: VALENCIA).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Income statement | ||
| Revenue | 7.88 | 8.47 |
| Revenue growth | -7.0% | - |
| EBITDA | 0.16 | 0.78 |
| EBITDA margin | +2.0% | +9.2% |
| Profit before tax | 1.09 | 1.07 |
| Net profit | 1.09 | 1.14 |
| Net profit margin | +13.8% | +13.5% |
| EPS (βΉ) | 0.60 | 0.63 |
| Balance sheet | ||
| Total assets | 57.33 | 38.07 |
| Net worth | 42.19 | 36.58 |
| Total debt | 15.13 | 1.49 |
| Cash & bank | 0.30 | 7.90 |
| Net working capital | 27.37 | 24.94 |
| Cash flow | ||
| Cash from operations | (8.19) | (15.73) |
| Cash from investing | (16.79) | (10.17) |
| Cash from financing | 17.39 | 33.57 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 6.64 | 8.47 | 1.34 | 1.46 | 0.00 | 0.95 | 2.37 |
| Revenue growth | -21.6% | +532.1% | -8.2% | - | -100.0% | -59.9% | - |
| EBITDA | 0.88 | 0.78 | (1.61) | (1.19) | (0.58) | (3.38) | (4.17) |
| EBITDA margin | +13.3% | +9.2% | -120.2% | -81.5% | - | -355.8% | -176.0% |
| Profit before tax | 1.05 | 1.07 | (1.38) | (1.26) | (0.67) | (3.58) | (4.33) |
| Net profit | 1.05 | 1.14 | (1.38) | (1.26) | (0.67) | (3.07) | (4.33) |
| Net profit margin | +15.8% | +13.5% | -103.0% | -86.3% | - | -323.2% | -182.7% |
| EPS (βΉ) | 1.72 | 0.63 | (2.48) | (2.26) | (1.18) | (6.40) | (7.76) |
| Balance sheet | |||||||
| Total assets | 51.14 | 38.07 | 3.29 | 1.51 | 1.19 | 1.82 | 5.57 |
| Net worth | 42.20 | 36.58 | (2.05) | (0.66) | 0.60 | 1.26 | 4.84 |
| Total debt | 8.94 | 1.49 | 5.34 | 2.18 | 0.60 | 0.56 | 0.65 |
| Cash & bank | 0.18 | 7.90 | 0.22 | 0.08 | 0.05 | 0.27 | 2.99 |
| Net working capital | 15.51 | 24.94 | 0.66 | 1.28 | 0.92 | 0.35 | 3.32 |
| Cash flow | |||||||
| Cash from operations | 3.40 | (15.73) | (0.76) | (1.55) | (1.35) | (2.49) | (4.10) |
| Cash from investing | (22.47) | (10.17) | (2.22) | 0.00 | 1.12 | (0.09) | (2.05) |
| Cash from financing | 11.35 | 33.57 | 3.13 | 1.58 | 0.42 | (0.17) | 8.89 |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Revenue | 7.88 | 8.47 |
| Revenue growth | -7.0% | - |
| Other income | 1.70 | 0.65 |
| Total expenses | 7.72 | 7.69 |
| Employee cost | 1.57 | 0.86 |
| EBITDA | 0.16 | 0.78 |
| EBITDA margin | +2.0% | +9.2% |
| Depreciation | 0.64 | 0.21 |
| Interest | 0.13 | 0.15 |
| Profit before tax | 1.09 | 1.07 |
| Tax | 0.00 | 0.00 |
| Net profit | 1.09 | 1.14 |
| Net profit margin | +13.8% | +13.5% |
| EPS (βΉ) | 0.60 | 0.63 |
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Equity & liabilities | ||
| Share capital | 18.32 | 16.98 |
| Reserves & surplus | 19.96 | 18.35 |
| Shareholders' funds (net worth) | 42.19 | 36.58 |
| Minority interest | 0.00 | 0.00 |
| Secured loans | 0.00 | 0.00 |
| Unsecured loans | 15.13 | 1.49 |
| Total debt | 15.13 | 1.49 |
| Total liabilities | 57.33 | 38.07 |
| Assets | ||
| Gross block | 17.36 | 6.88 |
| Net block | 15.89 | 6.04 |
| Capital work in progress | 10.67 | 0.14 |
| Investments | 1.75 | 2.93 |
| Inventories | 13.44 | 2.66 |
| Sundry debtors | 8.47 | 6.48 |
| Cash & bank balances | 0.30 | 7.90 |
| Loans & advances | 6.89 | 8.25 |
| Total current assets | 29.10 | 25.29 |
| Total current liabilities | 1.73 | 0.35 |
| Net working capital | 27.37 | 24.94 |
| Total assets | 57.33 | 38.07 |
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Opening cash | 7.90 | 0.22 |
| Net cash from operating activities | (8.19) | (15.73) |
| Net cash from investing activities | (16.79) | (10.17) |
| Net cash from financing activities | 17.39 | 33.57 |
| Net change in cash | (7.60) | 7.67 |
| Closing cash | 0.30 | 7.90 |
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Growth | ||
| Sales growth | -7.0% | - |
| EBITDA growth | -79.5% | - |
| PBT growth | +1.9% | +9997.0% |
| Net income growth | -4.4% | - |
| Profitability & leverage | ||
| Net income margin | +13.8% | +12.6% |
| Return on capital employed | +1.9% | +2.2% |
| Return on net worth | +1.9% | +2.0% |
| Debt / equity | 0.21 | 0.04 |
| Long-term debt / equity | 0.28 | 0.04 |
| Interest cover | -27.08 | 26.32 |
| Efficiency & per share | ||
| Fixed asset turnover | 0.65 | 1.23 |
| Inventory turnover | 0.98 | 3.18 |
| Debtors turnover | 1.05 | 1.31 |
| EPS (βΉ) | 0.60 | 0.63 |
| Dividend per share (βΉ) | 0.00 | 0.00 |
| Book value per share (βΉ) | 20.90 | 20.81 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 6.64 | 8.47 | 1.34 | 1.46 | 0.00 | 0.95 | 2.37 |
| Revenue growth | -21.6% | +532.1% | -8.2% | - | -100.0% | -59.9% | - |
| Other income | 0.84 | 0.65 | 0.31 | 0.00 | 0.00 | 0.02 | 0.00 |
| Total expenses | 5.76 | 7.69 | 2.95 | 2.65 | 0.58 | 4.33 | 6.54 |
| Employee cost | 0.00 | 0.86 | 0.32 | 0.21 | 0.16 | 0.94 | 2.09 |
| EBITDA | 0.88 | 0.78 | (1.61) | (1.19) | (0.58) | (3.38) | (4.17) |
| EBITDA margin | +13.3% | +9.2% | -120.2% | -81.5% | - | -355.8% | -176.0% |
| Depreciation | 0.54 | 0.21 | 0.05 | 0.07 | 0.08 | 0.13 | 0.12 |
| Interest | 0.13 | 0.15 | 0.03 | 0.00 | 0.01 | 0.09 | 0.04 |
| Profit before tax | 1.05 | 1.07 | (1.38) | (1.26) | (0.67) | (3.58) | (4.33) |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net profit | 1.05 | 1.14 | (1.38) | (1.26) | (0.67) | (3.07) | (4.33) |
| Net profit margin | +15.8% | +13.5% | -103.0% | -86.3% | - | -323.2% | -182.7% |
| EPS (βΉ) | 1.72 | 0.63 | (2.48) | (2.26) | (1.18) | (6.40) | (7.76) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 18.32 | 16.98 | 5.59 | 5.59 | 5.59 | 5.59 | 5.59 |
| Reserves & surplus | 19.97 | 18.35 | (7.64) | (6.25) | (4.99) | (4.33) | (0.75) |
| Shareholders' funds (net worth) | 42.20 | 36.58 | (2.05) | (0.66) | 0.60 | 1.26 | 4.84 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.44 |
| Unsecured loans | 8.94 | 1.49 | 5.34 | 2.18 | 0.60 | 0.56 | 0.21 |
| Total debt | 8.94 | 1.49 | 5.34 | 2.18 | 0.60 | 0.56 | 0.65 |
| Total liabilities | 51.14 | 38.07 | 3.29 | 1.51 | 1.19 | 1.82 | 5.57 |
| Assets | |||||||
| Gross block | 8.59 | 6.88 | 2.94 | 0.72 | 0.72 | 1.85 | 1.80 |
| Net block | 7.21 | 6.04 | 2.32 | 0.15 | 0.22 | 1.41 | 1.44 |
| Capital work in progress | 10.38 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Investments | 10.83 | 2.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 4.64 | 2.66 | 0.70 | 0.84 | 0.08 | 0.08 | 0.93 |
| Sundry debtors | 7.49 | 6.48 | 0.97 | 0.29 | 0.06 | 0.02 | 0.02 |
| Cash & bank balances | 0.18 | 7.90 | 0.22 | 0.08 | 0.05 | 0.27 | 2.99 |
| Loans & advances | 3.62 | 8.25 | 1.48 | 1.34 | 1.98 | 1.85 | 0.62 |
| Total current assets | 15.93 | 25.29 | 3.37 | 2.55 | 2.17 | 2.22 | 4.56 |
| Total current liabilities | 0.42 | 0.35 | 2.71 | 1.27 | 1.25 | 1.87 | 1.24 |
| Net working capital | 15.51 | 24.94 | 0.66 | 1.28 | 0.92 | 0.35 | 3.32 |
| Total assets | 51.14 | 38.07 | 3.29 | 1.51 | 1.19 | 1.82 | 5.57 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 7.90 | 0.22 | 0.08 | 0.05 | 0.23 | 2.99 | 0.26 |
| Net cash from operating activities | 3.40 | (15.73) | (0.76) | (1.55) | (1.35) | (2.49) | (4.10) |
| Net cash from investing activities | (22.47) | (10.17) | (2.22) | 0.00 | 1.12 | (0.09) | (2.05) |
| Net cash from financing activities | 11.35 | 33.57 | 3.13 | 1.58 | 0.42 | (0.17) | 8.89 |
| Net change in cash | (7.72) | 7.67 | 0.15 | 0.03 | 0.20 | (2.76) | 2.73 |
| Closing cash | 0.18 | 7.90 | 0.22 | 0.08 | 0.05 | 0.27 | 2.99 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -21.6% | +532.1% | -8.2% | - | -100.0% | -59.9% | - |
| EBITDA growth | +12.8% | +148.5% | -35.3% | -105.2% | +82.8% | +18.9% | - |
| PBT growth | -1.9% | +9998.0% | -9.5% | -88.1% | +81.3% | +17.3% | -103.3% |
| Net income growth | -7.9% | +182.6% | -9.5% | -88.1% | +78.2% | +29.1% | - |
| Revenue CAGR (3Y) | +65.7% | - | +12.2% | -14.9% | -100.0% | +32.3% | +48.1% |
| EBITDA CAGR (3Y) | - | - | -21.9% | -34.2% | -35.4% | +45.4% | +42.5% |
| Profitability & leverage | |||||||
| Net income margin | +15.8% | +12.6% | -103.0% | -86.3% | - | -376.8% | -182.7% |
| Return on capital employed | - | +4.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Return on net worth | - | +4.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt / equity | - | 0.20 | 0.00 | 0.00 | 0.62 | 0.20 | 0.15 |
| Long-term debt / equity | - | 0.20 | 0.00 | 0.00 | 0.42 | 0.12 | 0.14 |
| Interest cover | 38.24 | 26.32 | -1.81 | 0.00 | -1.52 | -2.56 | -0.93 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 1.73 | 0.73 | 2.03 | 0.00 | 0.52 | 2.20 |
| Inventory turnover | - | 5.04 | 1.74 | 3.17 | 0.00 | 1.88 | 3.65 |
| Debtors turnover | - | 2.27 | 2.13 | 8.34 | 0.00 | 47.50 | 31.60 |
| EPS (βΉ) | 1.72 | 0.63 | (2.48) | (2.26) | (1.18) | (6.40) | (7.76) |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 0.00 | 20.81 | (3.67) | (1.19) | 1.07 | 2.25 | 8.66 |
Timeline of Valencia Nutrition
5 dated milestones of Valencia Nutrition across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Valencia Nutrition is founded.
- Funding First funding round of $350K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $459K.
- IPO Lists on the stock exchange (IPO).
Competitors of Valencia Nutrition
Valencia Nutrition has 3 listed competitors in our database, 3 of them funded. They include Auric, Akiva Superfoods and Raskik.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| theauric.com | 2017 | Delhi, India | $5.54M | 38 | Ayurvedic nutrition drinks are manufactured and branded by Auric. | |
| akivasuperfoods.com | 2016 | Gurugram, India | $3.36M | 4 | Health care nutrition products are offered by Akiva Superfoods brand. | |
| raskik.com | 2019 | Gurugram, India | $1.61M | 6 | Nutrition drinks are branded and distributed by Raskik in India. |
Detailed competitors of Valencia Nutrition
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Valencia Nutrition
The website of Valencia Nutrition (valencianutrition.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 0.8% vs previous month
Top companies in Food & Beverage Products & Processing
3 companies that operate in the same segment as Valencia Nutrition (Food & Beverage Products & Processing) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Platform offering a subscription-based delivery service for fresh milk and groceries | 2015 | Gurugram, Haryana, India | USD 228.42 M | USD 99.78 M | 3,464 | |
Subscription-based coffee products are offered by an internet-first brand. | 2013 | Gurugram, Haryana, India | USD 112.84 M | USD 25.83 M | 2,059 | |
Meat and seafood products are delivered via an online platform. | 2015 | Bengaluru, Karnataka, India | USD 564.84 M | USD 143.51 M | 2,828 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Valencia Nutrition
Complete news archive for Valencia Nutrition
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valencia Nutrition
Valencia Nutrition was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Valencia Nutrition is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Deepthi Anand is the CEO of Valencia Nutrition, as recorded in our data. They have also founded this company.
Valencia Nutrition is a funded company, having raised a total of $1.78M across 5 funding rounds to date. The company's 1st funding round was a Seed of $350.05K, raised on Mar 2014.
Valencia Nutrition has 33 employees.
The primary company behind Valencia Nutrition, Valencia Nutrition Limited, reported revenue of βΉ9.58 Cr for FY 2026, down 7% year on year.
Valencia Nutrition Limited is involved in the production and distribution of fast-moving consumer goods with a focus on everyday nutrition. The company operates in sectors such as beverages, snacks, and personal care, offering affordable and accessible products. Solutions are developed by combining cultural ingredients with modern science to address nutritional needs. A presence is established across various industries in India, aiming for innovation and sustainable impact in the FMCG market.
Valencia Nutrition's top competitors include Auric, Raskik and Akiva Superfoods.
Valencia Nutrition offers Valencia Beverages, Valencia Snacks, and Valencia Perfumes.
Yes, Valencia Nutrition is publicly traded on BSE under the ticker symbol VALENCIA.
Valencia Nutrition has 8 investors. Key investors include Veer Equity, Orchid Consultancy Services, Manish Turakhia, H M Arvindkumar Ventures, and Chauhan Ventures.
The valuation of Valencia Nutrition is $2.53M as of Jun 2019.
